Catadman, Bb. Girl .
HRN: 22-41-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/24/2022
12/31/2022
IVTT
36mg
Q24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes